Literature DB >> 27870601

T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.

Rachel A Bender Ignacio1,2, Meena S Ramchandani1, Kerry J Laing1, Christine M Johnston1,2, David M Koelle1,2,3.   

Abstract

A woman presented with at least four manifestations of varicella-zoster virus (VZV) infection, including central nervous system vasculitis, during her first 2 years of HIV infection. We evaluated her CD4 T cell responses to VZV given the infrequency with which multiple recurrences of VZV occurred, especially following immune reconstitution on antiretroviral therapy.

Entities:  

Keywords:  CD4 response; HIV; VZV vasculitis; cellular immunology; herpes zoster; varicella-zoster virus

Mesh：

Year:  2016        PMID： 27870601      PMCID： PMC5220562          DOI： 10.1089/vim.2016.0097

Source DB:  PubMed          Journal:  Viral Immunol        ISSN： 0882-8245            Impact factor:   2.257


  21 in total

1.  Central nervous system-immune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke.

Authors:  S Y Teo; D Raha; D Warren; A Hassan; E Monteiro
Journal:  Int J STD AIDS       Date:  2014-01-09       Impact factor: 1.359

2.  Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.

Authors:  Ruanne V Barnabas; Jared M Baeten; Jairam R Lingappa; Katherine K Thomas; James P Hughes; Nelly R Mugo; Sinead Delany-Moretlwe; Glenda Gray; Helen Rees; Andrew Mujugira; Allan Ronald; Wendy Stevens; Saidi Kapiga; Anna Wald; Connie Celum
Journal:  J Infect Dis       Date:  2015-06-08       Impact factor: 5.226

3.  Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.

Authors:  Michael Boeckh; Hyung W Kim; Mary E D Flowers; Joel D Meyers; Raleigh A Bowden
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

4.  Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.

Authors:  Sophie Grabar; Pierre Tattevin; Hana Selinger-Leneman; Arnaud de La Blanchardiere; Pierre de Truchis; Christian Rabaud; David Rey; Vincent Daneluzzi; Samuel Ferret; Anne-Sophie Lascaux; Thomas Hanslik; Dominique Costagliola; Odile Launay
Journal:  Clin Infect Dis       Date:  2015-01-18       Impact factor: 9.079

5.  Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.

Authors:  Gianni E D'Egidio; Stephen Kravcik; Curtis L Cooper; D William Cameron; Dean A Fergusson; Jonathan B Angel
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

6.  CSF and MRI findings in patients with acute herpes zoster.

Authors:  M Haanpää; P Dastidar; A Weinberg; M Levin; A Miettinen; A Lapinlampi; P Laippala; T Nurmikko
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

7.  Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?

Authors:  Bienvenido G Yangco; Kate Buchacz; Rose Baker; Frank J Palella; Carl Armon; John T Brooks
Journal:  AIDS Patient Care STDS       Date:  2014-05-15       Impact factor: 5.078

8.  Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.

Authors:  Kerry J Laing; Ronnie M Russell; Lichun Dong; D Scott Schmid; Michael Stern; Amalia Magaret; Jürgen G Haas; Christine Johnston; Anna Wald; David M Koelle
Journal:  J Infect Dis       Date:  2015-03-17       Impact factor: 5.226

Review 9.  Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.

Authors:  Cecilia T Costiniuk; Dean A Fergusson; Steve Doucette; Jonathan B Angel
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

10.  Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.

Authors:  Lichen Jing; Kerry J Laing; Lichun Dong; Ronnie M Russell; Russell S Barlow; Juergen G Haas; Meena S Ramchandani; Christine Johnston; Soren Buus; Alec J Redwood; Katie D White; Simon A Mallal; Elizabeth J Phillips; Christine M Posavad; Anna Wald; David M Koelle
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.